François Dalençon

411 total citations
12 papers, 318 citations indexed

About

François Dalençon is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, François Dalençon has authored 12 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 5 papers in Molecular Biology and 3 papers in Epidemiology. Recurrent topics in François Dalençon's work include Immunotherapy and Immune Responses (3 papers), Immune Response and Inflammation (3 papers) and Lipid Membrane Structure and Behavior (2 papers). François Dalençon is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), Immune Response and Inflammation (3 papers) and Lipid Membrane Structure and Behavior (2 papers). François Dalençon collaborates with scholars based in France, Mexico and Canada. François Dalençon's co-authors include P. Hubert, E. Dellacherie, M. Léonard, Jean Haensler, Hatem Fessi, Christian Lafforgue, Jean‐François Cotte, Francis Derouin, Nicolas Burdin and Lynn D. Hawkins and has published in prestigious journals such as Journal of Controlled Release, International Journal of Pharmaceutics and Journal of Pharmaceutical Sciences.

In The Last Decade

François Dalençon

12 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
François Dalençon France 7 85 82 74 63 61 12 318
Kjersti Julin Norway 10 35 0.4× 80 1.0× 83 1.1× 92 1.5× 45 0.7× 14 343
Murtada A. Oshi South Korea 9 64 0.8× 218 2.7× 174 2.4× 96 1.5× 90 1.5× 15 531
Duy‐Khiet Ho Germany 12 58 0.7× 126 1.5× 89 1.2× 121 1.9× 62 1.0× 20 408
Dominique Lemoine Belgium 10 50 0.6× 226 2.8× 195 2.6× 162 2.6× 89 1.5× 12 570
Yousef Amini Iran 13 93 1.1× 49 0.6× 48 0.6× 115 1.8× 33 0.5× 27 371
Zora Rukavina Croatia 5 33 0.4× 89 1.1× 43 0.6× 122 1.9× 45 0.7× 8 301
P Arbós Spain 6 27 0.3× 201 2.5× 115 1.6× 77 1.2× 49 0.8× 6 408
Shalini Asthana India 11 17 0.2× 138 1.7× 74 1.0× 88 1.4× 43 0.7× 14 497
Kristin M. Tiemann United States 8 43 0.5× 43 0.5× 54 0.7× 136 2.2× 43 0.7× 10 406
Michael Washington United States 11 32 0.4× 34 0.4× 123 1.7× 113 1.8× 67 1.1× 34 445

Countries citing papers authored by François Dalençon

Since Specialization
Citations

This map shows the geographic impact of François Dalençon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Dalençon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Dalençon more than expected).

Fields of papers citing papers by François Dalençon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by François Dalençon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Dalençon. The network helps show where François Dalençon may publish in the future.

Co-authorship network of co-authors of François Dalençon

This figure shows the co-authorship network connecting the top 25 collaborators of François Dalençon. A scholar is included among the top collaborators of François Dalençon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with François Dalençon. François Dalençon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Syntin, Patrick, et al.. (2022). Nonclinical safety assessments of a novel synthetic toll-like receptor 4 agonist and saponin based adjuvant. Toxicology and Applied Pharmacology. 460. 116358–116358. 1 indexed citations
2.
Deauvieau, Florence, Aurore Fenis, François Dalençon, et al.. (2015). Lessons from NK Cell Deficiencies in the Mouse. Current topics in microbiology and immunology. 395. 173–190. 6 indexed citations
3.
Haensler, Jean, François Dalençon, Jean‐François Cotte, et al.. (2015). Design and preclinical characterization of a novel vaccine adjuvant formulation consisting of a synthetic TLR4 agonist in a thermoreversible squalene emulsion. International Journal of Pharmaceutics. 486(1-2). 99–111. 21 indexed citations
4.
Dalençon, François. (2013). Modern Vaccine Adjuvant/Formulation—Session 9: Adjuvants. Human Vaccines & Immunotherapeutics. 9(9). 2013–2014. 2 indexed citations
5.
Cotte, Jean‐François, et al.. (2012). Characterization of surfactants in an oil-in-water emulsion-based vaccine adjuvant using MS and HPLC–MS: Structural analysis and quantification. International Journal of Pharmaceutics. 436(1-2). 233–239. 10 indexed citations
6.
Dalençon, François, et al.. (2012). AF03, An Alternative Squalene Emulsion‐Based Vaccine Adjuvant Prepared by a Phase Inversion Temperature Method. Journal of Pharmaceutical Sciences. 101(12). 4490–4500. 59 indexed citations
7.
Guy, Bruno, François Dalençon, Christophe Grégoire, et al.. (2012). Improvement of Immunogenicity of Meningococcal Lipooligosaccharide by Coformulation with Lipidated Transferrin-Binding Protein B in Liposomes: Implications for Vaccine Development. Clinical and Vaccine Immunology. 19(5). 711–722. 6 indexed citations
8.
Léonard, M., et al.. (2004). Hydrophobically modified alginate hydrogels as protein carriers with specific controlled release properties. Journal of Controlled Release. 98(3). 395–405. 183 indexed citations
9.
Dalençon, François, Véronique Rosilio, & Adam Baszkin. (1999). Assessment of first-rate adsorption constants of platelet membrane proteins bearing liposomes by surface tension measurements. Colloids and Surfaces B Biointerfaces. 15(3-4). 195–201. 1 indexed citations
10.
Dalençon, François, et al.. (1997). Atovaquone and rifabutine-loaded nanocapsules: formulation studies. International Journal of Pharmaceutics. 153(1). 127–130. 22 indexed citations
11.
Dalençon, François, Véronique Rosilio, Philippe Manivet, Jean‐Marie Launay, & Adam Baszkin. (1997). Specific interactions between the human serotonin transporter and serotonin analogs at the solution/air interface. Colloids and Surfaces B Biointerfaces. 9(3-4). 197–203. 4 indexed citations
12.
Dalençon, François, Véronique Rosilio, F. Puisieux, Adam Baszkin, & Jean‐Luc Wautier. (1996). Liposomes bearing platelet proteins: a model for surface functions studies. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1302(3). 241–248. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kjersti Julin Breakdown of academic impact, for papers by Murtada A. Oshi Breakdown of academic impact, for papers by Duy‐Khiet Ho Breakdown of academic impact, for papers by Dominique Lemoine Breakdown of academic impact, for papers by Yousef Amini Breakdown of academic impact, for papers by Zora Rukavina Breakdown of academic impact, for papers by P Arbós Breakdown of academic impact, for papers by Shalini Asthana Breakdown of academic impact, for papers by Kristin M. Tiemann Breakdown of academic impact, for papers by Michael Washington
Rankless by CCL
2026